- Company
Fortune Media and Great Place To Work Name Vizient to ‘100 Best Companies to Work For’ in 2024
This is Vizient’s third time being named to this prestigious list. Earning a spot means that Vizient is one of the best companies to work for in the country.
- Company
Vizient announces agreement with Loma Linda University Health to provide solutions in expense management, quality benchmarking
The agreement includes a suite of Vizient spend management tools and access to operational and clinical analytics.
- Company
Vizient announces trends for providers to strategize in 2024
It’s a year for bold bets in payer strategy, ambulatory design, primary care access and technology adoption.
- Company
Vizient closes out 2023 with 37 new and renewed customers in Q4
The agreements reflect the value Vizient brings for providers seeking the alignment of cost, quality and market performance.
- Pharmacy
- Company
Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals
In addition, the anticipated expansion of gene therapies will increase provider spend even more.
- Company
Vizient Announces New and Renewed Customers for 2023
The new and renewed agreements reflect the value Vizient continues to bring hospitals and healthcare organizations.
- Company
Vizient Earns Top Score in Human Rights Campaign Foundation’s 2023-2024 Corporate Equality Index
The results showcase how U.S.-based companies are promoting LGBTQ+ friendly workplace policies in the U.S. and abroad.
- Company
Vizient Hosts Congressional Briefing on Mental and Behavioral Health
Yesterday on Capitol Hill, Vizient, Inc. held a policy briefing titled, “Communities in Crisis: How Hospitals are Addressing Mental and Behavioral Health Challenges in their Communities” at the Rayburn House Office Building.
- Company
Vizient Statement on CMS’ 340B Remedy Final Rule
Vizient responds to Centers for Medicare and Medicaid Services’ (CMS) final remedy for its unlawful 340B payment cuts from 2018 through a majority of 2022.
- Company
Fortune Media and Great Place To Work Name Vizient to 2023 Best Workplaces for Women List
This is Vizient’s second year in a row to be named to this prestigious list, and it means that Vizient is one of the best companies to work for in the country.
- Company
Vizient Offers Feedback on Mental Health Parity Proposed Rule
Vizient, Inc. offered feedback in response to the Administration’s proposed rule on updating requirements for the Mental Health Parity and Addiction Equity Act of 2008.
- Company
Vizient Shares Feedback on Improving Access to Rural Healthcare
Vizient, Inc. offered feedback in response to the House Ways and Means Committee's Request for Information on improving healthcare in rural and underserved areas.
- Company
- Supply Chain
Vizient Announces Top Performers in Clinical Quality, Supplier Diversity and Environmentally Preferred Sourcing Excellence
The awards recognize the work of Vizient provider customers in clinical quality and accountability, supplier diversity and environmentally preferred sourcing excellence and were presented during the 2023 Vizient Connections Summit in Las Vegas.
- Company
- Supply Chain
Vizient Recognizes 22 Suppliers and Distributors for Service Excellence
Vizient presented the awards at its annual Connections Summit in Las Vegas to recognize suppliers and distributors for delivering exceptional service to Vizient customer providers.
- Company
Vizient Pharmacy Leaders to Present at the FDA’s Compounding Quality Center of Excellence Conference
Vizient, Inc. pharmacy experts will speak at the Food and Drug Administration’s (FDA) Compounding Quality Center of Excellence 2023 Virtual Conference on September 12-13.
- Company
Vizient Offers Comments to CMS on Key Medicare Policies
Vizient, Inc. submitted comments on the Centers for Medicare and Medicaid Services (CMS) CY 2024 Medicare Hospital Outpatient Prospective Payment System (OPPS) and Physician Fee Schedule (PFS) proposed rules.
- Company
Vizient Offers Comments on CMS’ Proposed 340B Remedy
Vizient, Inc. offered comments on the Centers for Medicare and Medicaid Services (CMS) proposed 340B remedy.
- Company
- Data & Analytics
Vizient Report on Chronic Kidney Disease Finds Wide Variation in Rate of Screening Among Patient Populations Affecting Outcomes
The report, which utilizes data from Medicare’s Qualified Entity Program, explores outcomes through the lens of high social need communities, evaluating the cost and quality of care provided to patients with chronic kidney disease and end stage renal disea...
- Company
Vizient Releases 2022 Diversity, Equity and Inclusion (DEI) Report
The report highlights company progress in promoting a diverse, equitable and inclusive workplace for all employees.
- Company
Vizient’s Annual CSR Report Highlights Progress in Improving Health Equity and Sustainability in Healthcare Sector
Vizient announced it has published its annual corporate responsibility report detailing its focus on driving positive impacts across three interconnected pillars – people, places, and planet – by leveraging its unique position in the healthcare industry to...
- Company
- Data & Analytics
- Operations & Quality
Vizient Grants Public Access to the Vizient Vulnerability Index™ for Healthcare Providers to Assess Health Equity in their Communities
The access comes at no cost and provides a unique level of visibility for healthcare organizations to assess social determinants of health that impact health equity in the communities they serve. It is now available to anyone.
- Company
- Pharmacy
Vizient: Expansion of Specialty Drugs Driving a 3.42% Projected Increase in Hospital Pharmacy Spend
Vizient, Inc. projects a 3.42% increase in hospital pharmaceutical spend in its Summer Pharmacy Market Outlook, released July 31.
- Company
Vizient Joins White House Roundtable on Cancer Drug Shortages
Vizient, Inc. offers a statement about joining a White House roundtable discussion regarding cancer drug shortages.
- Company
Vizient Statement on CY 2024 Outpatient Prospective Payment System (OPPS) Proposed Rule
Vizient, Inc. offers a statement in response to the Centers for Medicare and Medicaid Services (CMS) CY 2024 Outpatient Prospective Payment System (OPPS) Proposed Rule
